Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Placebo
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Preoperative Genotyping
BRIGHT MINDS BIOSCIENCES INC.
PPAP
1 trial -
Preoperative three-dimensional reconstruction
Universal Integrated
Kidney Neoplasms / Surgery
1 trial -
Prepackaged Low-Residue Diet
Universal Integrated
Bowel Preparation Solution
1 trial -
Prepackaged Low-residue diet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colon Polyp
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Cessation
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
2 trials -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Cessation
1 trial -
Progesterone
Hospital Authority, Hong Kong
Preterm
1 trial -
Protein intake
Ultragenyx UK Limited
Phenylketonuria
1 trial -
Protocol-based management of perioperative antithrombotic therapy
Peking University Third Hospital
Antithrombotic Therapy
1 trial -
Protocol-based management of perioperative antithrombotic therapy
The First People's Hospital of Lianyungang
Antithrombotic Therapy
1 trial -
R-CDOP
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial -
RNL-Vascostem®
Cellectar Biosciences
Buerger's Disease
1 trial -
Radiotherapy combined with TKI and Anti-PD-1 Antibody
Jian Li
Stage IIIA Hepatocellular Carcinoma
1 trial -
Reduction CTVp1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Regen Matrix-PRP-XLHA
Regeneron Ireland Designated Activity Company (DAC)
Knee Osteoarthritis
1 trial -
Remimazolam
The First People's Hospital of Lianyungang
Sedation and Analgesia
1 trial -
Remodulin
United Therapeutics Europe Ltd
Congenital Heart Disease
1 trial -
Ringer's solution acetate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cholecystolithiasis and Thyroid Nodule
1 trial -
Ropivacaine
The First People's Hospital of Lianyungang
Surgery
1 trial -
Ropivacaine
Lei Xiaoming
Cystic Adenomatoid Malformation of Lung, Congenital
1 trial -
Routine Medication
The First People's Hospital of Lianyungang
Generalized Anxiety Disorder
1 trial -
Semaglutide, 0.5 mg/mL
United Therapeutics Europe Ltd
Cognitive Change
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources